Pharion Speciality Medicines

Esentra Denosumab Injection 120 mg is a monoclonal antibody used to manage bone-related complications in cancer patients and certain bone disorders. It works by inhibiting RANKL, reducing bone resorption and strengthening bone structure. Administered via subcutaneous injection, it should be used strictly under medical supervision.

Olimab Denosumab Injection 60 mg is a monoclonal antibody used in the treatment of bone disorders such as osteoporosis and to reduce the risk of fractures. It works by inhibiting RANKL, thereby decreasing bone resorption and increasing bone strength. It is administered as a subcutaneous injection under medical supervision as per prescribed treatment guidelines.

Treifrac Teriparatide Injection 750 mcg is used in the treatment of osteoporosis in patients at high risk of fractures. It is a recombinant parathyroid hormone that stimulates new bone formation, improves bone mineral density, and enhances bone strength. The injection is given subcutaneously and should be used strictly under medical supervision as per the prescribed treatment plan.

Hytasone Hyaluronic Acid Injection 8 mg is used in the management of joint disorders such as osteoarthritis. It helps lubricate and cushion the joint, reducing pain and improving mobility. By restoring the viscoelastic properties of synovial fluid, it supports smoother joint movement. The injection is administered intra-articularly under medical supervision.

Zotide 600 mcg Injection contains Teriparatide, a recombinant form of parathyroid hormone used to treat osteoporosis in postmenopausal women and men at high risk of fractures. It promotes new bone formation, increases bone density, and strengthens the skeleton, effectively reducing the risk of spine and hip fractures.

ROZEL 60 Injection contains Denosumab, a monoclonal antibody used to treat osteoporosis and bone loss associated with cancer. It strengthens bones, reduces fracture risk, and improves bone density. Administered subcutaneously under medical supervision only.

60 mg Denoci-OP (Denosumab) Injection is used to treat osteoporosis and prevent bone loss in high-risk patients. It works by inhibiting RANKL, helping strengthen bones and reduce fracture risk under medical supervision.